Review on bortezomib resistance in multiple myeloma and potential role of emerging technologies

Kozalak, Gül and Bütün, İsmail and Toyran, Erçil and Koşar, Ali (2023) Review on bortezomib resistance in multiple myeloma and potential role of emerging technologies. Pharmaceuticals, 16 (1). ISSN 1424-8247

Full text not available from this repository. (Request a copy)


Multiple myeloma is a hematological cancer type. For its treatment, Bortezomib has been widely used. However, drug resistance to this effective chemotherapeutic has been developed for various reasons. 2D cell cultures and animal models have failed to understand the MM disease and Bortezomib resistance. It is therefore essential to utilize new technologies to reveal a complete molecular profile of the disease. In this review, we in-depth examined the possible molecular mechanisms that cause Bortezomib resistance and specifically addressed MM and Bortezomib resistance. Moreover, we also included the use of nanoparticles, 3D culture methods, microfluidics, and organ-on-chip devices in multiple myeloma. We also discussed whether the emerging technology offers the necessary tools to understand and prevent Bortezomib resistance in multiple myeloma. Despite the ongoing research activities on MM, the related studies cannot provide a complete summary of MM. Nanoparticle and 3D culturing have been frequently used to understand MM disease and Bortezomib resistance. However, the number of microfluidic devices for this application is insufficient. By combining siRNA/miRNA technologies with microfluidic devices, a complete molecular genetic profile of MM disease could be revealed. Microfluidic chips should be used clinically in personal therapy and point-of-care applications. At least with Bortezomib microneedles, it could be ensured that MM patients can go through the treatment process more painlessly. This way, MM can be switched to the curable cancer type list, and Bortezomib can be targeted for its treatment with fewer side effects.
Item Type: Article
Uncontrolled Keywords: 3D cell culture; Bortezomib; microfluidic; multidrug resistance; multiple myeloma; nanoparticle; organ-on-chip
Divisions: Faculty of Engineering and Natural Sciences
Depositing User: Ali Koşar
Date Deposited: 17 Apr 2023 15:09
Last Modified: 17 Apr 2023 15:09

Actions (login required)

View Item
View Item